Shop

ReGrow 3Active by RPM Health blends Minoxidil 5%, Finasteride 0.1%, and Melatonin 0.1% to combat androgenetic alopecia. This synergistic formula stimulates hair growth, reduces loss, and enhances scalp health

ReGrow 3Active ‘ by RPM Health is a specially formulated solution combining Minoxidil 5%, Finasteride 0.1%, and Melatonin 0.1%. This unique blend is designed to address various types of hair loss, including androgenetic alopecia, by targeting hair follicles directly to stimulate growth and prevent further loss.

Active Ingredients:

• Minoxidil 5%: A potent vasodilator that improves blood flow to hair follicles, promoting hair regrowth and prolonging the growth phase of the hair cycle.
• Finasteride 0.1%: A 5-alpha-reductase inhibitor that prevents the conversion of testosterone to dihydrotestosterone (DHT), a hormone that contributes to hair follicle shrinkage and hair loss.
• Melatonin 0.1%: Known for its antioxidant properties, melatonin also plays a role in regulating hair growth cycles and protecting hair follicles from oxidative stress.

Benefits:

• Enhanced Hair Growth: The combination of Minoxidil and Finasteride is clinically proven to significantly enhance hair regrowth by both increasing blood flow to hair follicles and reducing harmful DHT levels.
• Reduced Hair Loss: Finasteride helps in slowing down and potentially stopping hair loss by targeting the hormonal cause of androgenetic alopecia.
• Scalp Health: Melatonin’s antioxidant properties protect hair follicles from damage, promoting a healthier scalp environment for hair growth.
• User Convenience: The topical formulation allows for targeted application directly to the scalp, minimizing systemic absorption and reducing the likelihood of systemic side effects.
• Dual Action: Combining vasodilation and hormonal inhibition offers a synergistic effect, making the treatment more effective than using either ingredient alone.

Application:

• Apply the tonic directly to the affected areas of the scalp once or twice daily, as directed by your healthcare provider.
• Ensure the scalp is dry before application.
• Use consistently for several months to observe noticeable improvements.

Summary

Minoxidil / Finasteride Solution is a topical solution that is a combination of drug products that have been formulated to address androgenetic alopecia, the most prevalent form of hair loss, which is influenced by genetics and hormonal changes. The active ingredients in this preparation function in a synergistic manner to mitigate the effects of testosterone metabolism and facilitate hair regrowth. The affected area is treated with the preparation twice daily, and it may require up to four months of therapy to observe a response.

Minoxidil

Minoxidil, which was previously employed as an oral medication to treat high blood pressure, is now commonly applied topically to promote hair growth without causing systemic vasodilation.One Regarding hair regrowth, the mechanism of action is unknown; however, research indicates that it reduces the latent period of the hair cycle, which is the interval between the shedding of telogen (resting) hair and the commencement of the subsequent growth phase. In other words, topical minoxidil may induce the shed of follicles in the telogen phase, which are subsequently replaced by thicker hairs in a new anagen (growth) phase.

When administered during the initial stages of alopecia, topical minoxidil is generally well-tolerated and may be effective independently. It is probable that it is effective in fostering moderate hair growth in approximately 30% of men and 60% of women who are experiencing androgenetic hair loss.Four Minoxidil is also recognised for its ability to mitigate the progression of alopecia or induce mild hair growth.

Finasteride

The enzyme 5-alpha reductase is employed by the body to convert testosterone into dihydrotestosterone (DHT) during normal testosterone metabolism. Hair follicles have been demonstrated to contract and be damaged by prolonged exposure to DHT. This pathway is suspected to be a contributing factor to the progression of androgenetic alopecia, as 5-Alpha reductase is present in the oil glands of hair follicles. Researchers have discovered that hair follicle miniaturisation can be slowed or halted by suppressing the production of DHT if detected early enough.

This formulation contains finasteride, a potent inhibitor of 5-alpha reductase. It was initially approved by the FDA to enhance and sustain the maximum urine flow rate in men who are experiencing benign prostatic hyperplasia (BPH), a prevalent condition among men over the age of 50. It was subsequently approved as an oral treatment for mild to moderate male pattern baldness of the vertex and anterior mid-scalp area in men. In comparison to topical minoxidil alone, researchers have discovered that the combination of topical finasteride and topical minoxidil may yield superior results. Low libido, erectile dysfunction, reduced ejaculatory volume, and gynaecomastia are among the most prevalent adverse effects of oral finasteride. Fortunately, research has shown that topical finasteride has a significantly lower systemic absorption than oral formulations, which may prevent the occurrence of these adverse effects while still achieving comparable therapeutic results.

Melatonin

Melatonin , known for regulating sleep, also benefits hair growth. It possesses strong antioxidant properties, protecting hair follicles from oxidative stress and damage. Melatonin extends the anagen (growth) phase of the hair cycle, promoting longer and thicker hair. Its anti-inflammatory effects soothe the scalp, improving overall scalp health. Additionally, melatonin may reduce DHT levels, a hormone linked to hair loss, and stimulate hair follicles to encourage new growth. By enhancing follicle survival under stress, melatonin supports hair density and strength, making it a valuable ingredient in hair growth formulations.